Summit Therapeutics Share Discussion Threads

[hugus maximus] 07/3/2017 13:36

The share price is only just slightly nipping below the NASDAQ which is currently exchanging at £2.07. Over the past few days the AIM share has been running way above the NASDAQ price. Perhaps the MM's are using the current sellers as a reason to adjust the price back down again?

[solomon] 07/3/2017 11:37

football: yes, unusually volatile for the AIM listing. Probably catching the disease from the NASDAQ trading pattern. One trade there can change the quoted price by several %
abergele, FM2, yes I agree that it is probably a small price to pay (rollover, bed&ISA, whatever) for an eventual payout but I think the brokers make quite an unwarrented profit.

[football] 07/3/2017 11:15

£6.5mil knocked off the market cap price with just 8000 shares being sold


:(

[freemoney2] 06/3/2017 20:58

Yep, if we multi-bag here as expected then the tax savings within an ISA will far exceed costs of a bed and ISA transaction.
Looking forward to April 6th to move a bunch more :-)

[abergele] 06/3/2017 20:46

Aye Solomon,my thoughts,
still expensive but worth the while if selling and putting in his ISA top up?
If they have nearly used their allowances,every little helps,but costly all the same..gl

[solomon] 06/3/2017 16:39

If that was a rollover this afternoon, it's not a cheap way of doing things. I would baulk at paying £285 just keep the ball rolling.

[abergele] 04/3/2017 21:08

Kabo,
Many thanks for the www,links,makes good reading and food for thought for newbies

[kabo87] 04/3/2017 01:08

hTTps://www.americanbankingnews.com/2017/03/03/summit-therapeutics-plc-smmt-receives-consensus-rating-of-buy-from-analysts.html

[kabo87] 04/3/2017 01:08

https://www.americanbankingnews.com/2017/03/03/summit-therapeutics-plc-smmt-receives-consensus-rating-of-buy-from-analysts.html

[luminoso] 03/3/2017 17:25

Sarepta also up. Could just be part of the froth over in the US for growth stocks at the moment. Techs also doing well. Would like to think it bodes well for an announcement but we've been here before. Nice to see £2 left behind for now and long may it continue. Good week-end all !

[bewise2] 03/3/2017 15:35

Ticking up nicely on nasdaq..13.20

[hugus maximus] 03/3/2017 13:24

Waterloo .. that's also a very good comprehensive explanation of the science for those who might want to get a grip of some nitty gritty. The incredibly encouraging development of the biomarker work puts us in a very different position with the FDA compared to Sarepta ... much more belt and braces. There seems to be much ground very well covered by the team. Excellent.

[waterloo01] 03/3/2017 12:02

In conclusion, we have identified several serological protein biomarkers to assist in the development of utrophin modulation strategies for DMD. Among 1,310 proteins, we progressively selected well-documented and undiscovered mdx markers, all rescued in the mdx transgenic Fiona mice. We therefore defined a final panel of 15 therapeutic monitoring biomarkers and confirmed five markers, easily measured in an automated fashion by ELISA. This work may help in the evaluation of Ezutromid currently in a clinical phase 2 trials and should accelerate development of future generations of utrophin modulators for a more rapid translation to DMD patients.

[football] 03/3/2017 11:09

TRADER'S CHEAT SHEET for Fri, Mar 3rd, 2017

Summit Therapeu ADR (SMMT) NASDAQ
12.85 +0.12 (+0.94%) 03/02/17

[abergele] 03/3/2017 10:17

I wouldn't like to be out of this in the next 7-10 days ahead,chart wise ,
in case as you think we could have news maybe following ...gl

[abergele] 03/3/2017 10:11

Morning H.M.
It's awful trying to predict ,as in time as we know from our experience of the £2.50 peak,shot uo and faded away to £1.40,painful for many Lth's.


I tend to watch charts inbetween news,trying to see a new entry point if it's falling away waiting for theat specific news..I don't sell when it drops,can't be bothered, want a peaceful life,haa.

We saw the last spike from a 5 month gap between rises, and if matters progress the same we are due another quite soon,could be a week away,OR not,as I say,I tend to watch charts ,and you break to me the news,,good lad....anything I say is from a perspective that don't gamble only what you can affrd to lose and what wont change your life if it goes wrong...so much of the markets today are a gamble and not an investment as was 20/30 or so years ago, as when it was easier to invest.gl

take care .

[hugus maximus] 03/3/2017 09:40

Morning abergale ... how far do you see "long term" over only £2.70? I was rather hoping for many times that in my long term ;-) (i.e. My long term has already been some time, so was anticipating the end of 2017 being potentially double that)

I had a chat with Richard Pie this week who said that Q2/Q3 is still on schedule for some initial 24 wk DMD Phase Out report. If there is some actual positive data there, surely there'll be huge share price movement in response?

[bewise2] 03/3/2017 09:31

Were are due results for cdiff & dmd in quarters 2/3 so i would imagine a share price much much higher than 2.70 hence the current rise in share price in expectation.....on down the road our share price will be multiples of were it is now if everything goes to plan.....

[abergele] 03/3/2017 09:24

morning,..
long term I see this £2.70p,
when ,well depends on sellers to buyers of course..imho

[luminoso] 03/3/2017 09:20

More likely a gathering shift from SRPT to SMMT in US. But wtfdik.

[hugus maximus] 03/3/2017 09:06

Half a million shares reported yesterday and another 5p just ticked up? Summut up? RNS?

[waterloo01] 02/3/2017 14:41

Same drug as they have conditional approval for nonsense mutation.